Nanotechnology in Drug Delivery and Targeted Therapeutics is redefining the future of precision medicine by enabling ultra-specific, highly efficient, and safer treatment modalities. As nanoscience advances, engineered nanocarriers are unlocking unprecedented opportunities to overcome biological barriers and deliver therapeutic agents exactly where they are needed, minimizing side effects and maximizing efficacy.

At the Conference on Nanotechnology and Materials Science 2026, this session will bring together pioneering researchers, pharmaceutical innovators, and biomedical engineers shaping the next era of therapeutic intervention.

We invite submissions and expert talks on:

• Nanocarriers for Targeted Drug Delivery: Exploring the design and functionalization of nanoparticles, liposomes, dendrimers, and micelles for site-specific drug release.

• Stimuli-Responsive and Smart Drug Delivery Systems: Discussing nanomaterials that respond to internal (pH, enzymes) or external (temperature, light, magnetic fields) stimuli to release therapeutic payloads precisely when and where needed.

• Nanotechnology-Enabled Gene and RNA Delivery: Advancements in nanoparticle-mediated delivery of DNA, siRNA, mRNA, and CRISPR/Cas systems for genetic therapies and personalized medicine.

• Crossing Biological Barriers: Innovative strategies to navigate challenges like the blood-brain barrier, tumor microenvironments, and mucosal tissues using nano-enabled systems.

• Immunomodulatory Nanoparticles: Designing nanoplatforms to enhance immunotherapy, vaccine delivery, and modulation of immune responses for cancer, infectious diseases, and autoimmune conditions.

• Biodegradable and Biocompatible Nanomaterials: Highlighting sustainable, non-toxic carriers that safely degrade post-therapy without long-term accumulation or toxicity.

• Targeted Cancer Therapeutics: Cutting-edge approaches using ligand-decorated nanoparticles for active targeting of tumor cells, tumor microenvironment modulation, and combination therapies (chemo, radio, photo, and immunotherapy).

• Intracellular Delivery and Organellar Targeting: Nanocarriers designed for precision delivery into specific organelles such as mitochondria, nucleus, or lysosomes for enhanced therapeutic outcomes.

• Nanotechnology in Antiviral and Antibacterial Therapies: Discussing nanoparticle systems developed for tackling viral infections (including mRNA vaccine delivery) and antibiotic-resistant bacterial strains.

• Real-Time Monitoring and Theranostics: Integration of imaging agents into nanocarriers for simultaneous diagnosis, therapy (theranostics), and real-time tracking of treatment response.

• Personalized Nanomedicine: Advances in tailoring nanoparticle formulations based on patient-specific biomarkers, genomics, and pharmacogenomics.

• Clinical Translation Challenges and Opportunities: Addressing scalability, regulatory hurdles, manufacturing, and commercialization pathways for nano-enabled therapeutics.

• Nanotoxicology and Safety Assessments: Evaluating the biosafety, biodistribution, pharmacokinetics, and long-term effects of nanomaterials in clinical settings.

This session will serve as a dynamic platform for discussing the breakthroughs, challenges, and translational pathways of nanotechnology-driven therapeutic innovations poised to transform global healthcare.

Join us at the Conference on Nanotechnology and Materials Science 2026 to be part of the conversation driving the future of precision drug delivery and targeted therapeutics!